Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R McLean

Showing results (531-540 of 631) with videos related to

Pageof 64
Sort By:
Dermatology and Therapy|December 30, 2022
Real-World Effectiveness of 9-12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis RegistryApril W Armstrong, Timothy Fitzgerald, Robert R McLean, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 7, 2006
Association of dietary and biochemical measures of vitamin K with quantitative ultrasound of the heel in men and womenR R McLean, S L Booth, D P Kiel, et al.
Advances in Therapy|March 17, 2023
The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis RegistryApril W Armstrong, Timothy Fitzgerald, Robert R McLean, et al.
Dermatology and Therapy|November 17, 2022
Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis RegistryChen Yu, Gang Wang, Russel T Burge, et al.
Pharmaceutics|November 27, 2025
Post-Synthesis Modulation of the Physicochemical Properties of Green-Synthesized Iron Oxide Nanoparticles with Tween 80 to Enhance Their Antibacterial Activity and BiocompatibilityMarwa R Bakkar, Alaa M Ali, Gehad E Elkhouly, et al.
Dermatology and Therapy|September 27, 2023
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis RegistryRobert R McLean, Adam P Sima, Silky Beaty, et al.
Clinical and Diagnostic Laboratory Immunology|January 11, 2003
Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannanJosephine Anne D Navoa, Suman Laal, Liise-Anne Pirofski, et al.
Dermatology and Therapy|December 9, 2022
Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis RegistryApril W Armstrong, Timothy Fitzgerald, Robert R McLean, et al.
The Journal of Clinical Endocrinology and Metabolism|November 8, 2007
Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of menMarian T Hannan, Heather J Litman, Andre B Araujo, et al.
Proceedings. Biological Sciences|October 30, 2015
A restatement of recent advances in the natural science evidence base concerning neonicotinoid insecticides and insect pollinatorsH Charles J Godfray, Tjeerd Blacquière, Linda M Field, et al.
Pageof 64

Showing results (531-540 of 631) with videos related to

Sort By:
Pageof 64
Dermatology and Therapy|December 30, 2022
Real-World Effectiveness of 9-12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis RegistryApril W Armstrong, Timothy Fitzgerald, Robert R McLean, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 7, 2006
Association of dietary and biochemical measures of vitamin K with quantitative ultrasound of the heel in men and womenR R McLean, S L Booth, D P Kiel, et al.
Advances in Therapy|March 17, 2023
The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis RegistryApril W Armstrong, Timothy Fitzgerald, Robert R McLean, et al.
Dermatology and Therapy|November 17, 2022
Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis RegistryChen Yu, Gang Wang, Russel T Burge, et al.
Pharmaceutics|November 27, 2025
Post-Synthesis Modulation of the Physicochemical Properties of Green-Synthesized Iron Oxide Nanoparticles with Tween 80 to Enhance Their Antibacterial Activity and BiocompatibilityMarwa R Bakkar, Alaa M Ali, Gehad E Elkhouly, et al.
Dermatology and Therapy|September 27, 2023
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis RegistryRobert R McLean, Adam P Sima, Silky Beaty, et al.
Clinical and Diagnostic Laboratory Immunology|January 11, 2003
Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannanJosephine Anne D Navoa, Suman Laal, Liise-Anne Pirofski, et al.
Dermatology and Therapy|December 9, 2022
Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis RegistryApril W Armstrong, Timothy Fitzgerald, Robert R McLean, et al.
The Journal of Clinical Endocrinology and Metabolism|November 8, 2007
Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of menMarian T Hannan, Heather J Litman, Andre B Araujo, et al.
Proceedings. Biological Sciences|October 30, 2015
A restatement of recent advances in the natural science evidence base concerning neonicotinoid insecticides and insect pollinatorsH Charles J Godfray, Tjeerd Blacquière, Linda M Field, et al.
Pageof 64